Chlamydia Persistence: A Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo

Area of Science:

• Microbiology
• Bacterial Pathogenesis
• Infectious Diseases

Background:

• Chlamydiaceae are obligate intracellular bacteria with three human pathogens: Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psittaci.
• Chlamydia trachomatis causes STIs and blindness; C. pneumoniae causes pneumonia; C. psittaci causes psittacosis in humans.
• Antimicrobial resistance is not a major issue for Chlamydia, but persistence is a key survival mechanism.

Purpose of the Study:

• To review Chlamydia survival strategies against antimicrobial agents and host immune responses.
• To focus on models used to study Chlamydia persistence.
• To elucidate the molecular basis of persistence and its implications for animal models.

Main Methods:

• Review of existing literature on Chlamydia survival strategies.
• Analysis of different experimental models for studying Chlamydia persistence.
• Examination of molecular mechanisms underlying persistence.

Main Results:

• Chlamydia enters a viable but non-cultivable state (persistence) under stress, such as antimicrobial exposure.
• Persistence involves temporary interruption of the replication cycle.
• Upon removal of stress, Chlamydia resumes replication and infectivity.

Conclusions:

• Chlamydia employs diverse survival strategies, including persistence, to evade host defenses and antimicrobial treatments.
• Understanding Chlamydia persistence models is crucial for developing effective therapeutic strategies.
• Further research using animal models is needed to translate findings into clinical applications.